Collagenase-2 (MMP-8) and matrilysin-2 (MMP-26) expression in human wounds of different etiologies

Wound Repair and Regeneration

Volumn 15, Issue 1, 2007, Pages 47-57

  Pirilä, Emma ^a   Korpi, Jarkko T ^a   Korkiamäki, Timo ^a   Jahkola, Tiina ^b   Gutierrez Fernandez, Ana ^c   Lopez Otin, Carlos ^c   Saarialho Kere, Ulpu ^d,e   Salo, Tuula ^a   Sorsa, Timo ^d  

^a UNIVERSITY OF OULU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^d UNIVERSITY OF HELSINKI   (Finland)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 26; NEUTROPHIL COLLAGENASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; KERATINOCYTE; MALE; MOUTH MUCOSA; MUCOSA CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN EPITHELIUM; SKIN INJURY; WOUND HEALING;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASES, SECRETED; MIDDLE AGED; SKIN ULCER; VARICOSE ULCER; VASCULITIS; WOUND HEALING;

EID: 33846413555     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2006.00184.x     Document Type: Article

References (40)

1. Trowbridge HO, Emling RC. Inflammation: a review of the process. Chicago: Quintessence Publishing Co. Inc, 1989.
2. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehab 2005; 26: 306-19.
3. Whitney JD. Overview: acute and chronic wounds. Nurs Clin North Am 2005; 40: 191-205.
4. Martin P. Wound healing - aiming for the perfect skin regeneration. Science 1997; 276: 75-81.
5. Lopez-Otin C, Overall CM. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 2002; 3: 509-19.
6. Lund LR, Rømer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RV, Danø K. Functional overlap between two classes of matrix-degrading proteases in wound healing. Embo J 1999; 18: 4645-56.
7. Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 1990; 265: 11421-4.
8. Balbin M, Fueyo A, Tester AM, Pendas AM, Pitiot AS, Astudillo A, Overall CM, Shapiro SD, Lopez-Otin C. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003; 35: 252-7.
9. Montel V, Kleeman J, Agarwal D, Spinella D, Kawai K, Tarin D. Altered metastatic behavior of human breast cancer cells after experimental manipulation of matrix metalloproteinase 8 gene expression. Cancer Res 2004; 64: 1687-94.
10. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD. Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J Immunol 2004; 172: 7791-803.
11. Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999; 81: 189-95.
12. Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE, Sang QXA. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 2000; 275: 20540-4.
13. Uria JA, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 2000; 60: 4745-51.
14. Isaka K, Nishi H, Nakai H, Nakada T, Li YF, Ebihara Y, Takayama M. Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma. Cancer 2003; 97: 79-89.
15. Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI, Strongin AY. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 2001; 256: 705-18.
16. Bister V-O, Salmela MT, Karjalainen-Lindsberg M-L, Uria J, Lohi J, Puolakkainen P, Lopez-Otin C, Saarialho-Kere U. Differential expression of three matrix metalloproteinase, MMP-19, MMP-26 and MMP-28, in normal and inflamed intestine and colon cancer. Dig Dis Sci 2004; 49: 653-61.
17. Marchenko ND, Marchenko GN, Weinreb RN, Lindsey JD, Kyshtoobayeva A, Crawford HC, Strongin AY. β-catenin regulates the gene of MMP-26, a novel matrix metalloproteinase expressed both in carcinomas and normal epithelial cells. Int J Biochem Cell Biol 2004; 36: 942-56.
18. Zhao Y-G, Xiao A-Z, Park HI, Newcomer RG, Yan M, Man Y-G, Heffelfinger SC, Sang QXA. Endometase/Matrilysin-2 in human breast carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinase-2 and -4: a putative role in the initiation of breast cancer invasion. Cancer Res 2004; 64: 590-8.
19. Zhao Y-G, Xiao A-Z, Newcomer RG, Park HI, Kang T, Chung LWK, Swanson MG, Zhau HE, Kurhanewicz J, Sang QXA. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem 2003; 278: 15056-64.
20. Puente XS, Lopez-Otin C. A genomic analysis of rat proteases and protease inhibitors. Genome Res 2004; 14: 609-22.
21. Puente XS, Sánchez LM, Overall CM, López-Otín C. Human and mouse proteases: a comparative genomic approach. Nat Rev Gen 2003; 4: 544-58.
22. Vaalamo M, Weckroth M, Puolakkainen P, Saarinen P, Kere J, Lauharanta J, Saarialho-Kere U. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol 1996; 135: 52-9.
23. Mirastschijski U, Impola U, Jahkola T, Karlsmark T, Ågren M, Saarialho-Kere U. Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds. Hum Pathol 2002; 33: 355-64.
24. Pirilä E, Ramamurthy N, Maisi P, McClain S, Kucine A, Wahlgren J, Golub L, Salo T, Sorsa T. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr Med Chem 2001; 8: 281-94.
25. Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Rönkä H, Tschesche H, Salo T. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997; 272: 31504-9.
26. Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 1994; 70: 176-82.
27. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999; 17: 768-74.
28. Tervahartiala T, Pirilä E, Ceponis A, Maisi P, Salo T, Tuter G, Kallio P, Tornwall J, Srinivas R, Konttinen YT, Sorsa T. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000; 79: 1969-77.
29. Moilanen M, Pirilä E, Grenman R, Sorsa T, Salo T. Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 2002; 197: 72-81.
30. Siller-Lopez F, Sandoval A, Salgado S, Salazar A, Bueno M, Garcia J, Vera J, Galvez J, Hernandez I, Ramos M, Aguilar-Cordova E, Armendariz-Borunda J. Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology 2004; 126: 1122-33.
31. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997; 137: 1445-57.
32. Hartenstein B, Dittrich BT, Stickens D, Hever B, Vu TH, Teurich S, Schorpp-Kistner M, Werb Z, Angel P. Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol 2006; 126: 486-96.
33. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kähäri VM, Saarialho-Kere U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997; 109: 96-101.
34. Impola U, Jeskanen L, Ravanti L, Syrjänen S, Baldursson B, Kähäri V-M, Saarialho-Kere U. Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds. Br J Dermatol 2005; 152: 720-6.
35. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-6.
36. Ryan ME, Ramamurthy NS, Sorsa T, Golub LM. MMP-mediated events in diabetes. Ann NY Acad Sci 1999; 878: 311-34.
37. Li W, Savinov AY, Rozanov DV, Golubkov VS, Hedayat H, Postnova TI, Golubkova NV, Linli Y, Krajewski S, Strongin AY. Matrix metalloproteinase-26 is associated with estrogen-dependent malignancies and targets α1-antitrypsin serpin. Cancer Res 2004; 64: 8657-65.
38. Dunsmore SE, Saarialho-Kere UK, Roby JD, Wilson CL, Matrisian LM, Welgus HG, Parks WC. Matrilysin expression and function in airway epithelium. J Clin Invest 1998; 102: 1321-31.
39. Ahokas K, Skoog T, Suomela S, Jeskanen L, Impola U, Isaka K, Saarialho-Kere U. Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis. J Invest Dermatol 2005; 124: 849-56.
40. Krampert M, Bloch W, Sasaki T, Bugnon P, Rülicke T, Wolf E, Aumailley M, Parks WC, Werner S. Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 2004; 15: 5242-54.